266 related articles for article (PubMed ID: 22425074)
1. Half of visible and half of recurrent visible hematuria cases have underlying pathology: prospective large cohort study with long-term followup.
Mishriki SF; Vint R; Somani BK
J Urol; 2012 May; 187(5):1561-5. PubMed ID: 22425074
[TBL] [Abstract][Full Text] [Related]
2. Incidence of recurrent frank hematuria and urological cancers: prospective 6.9 years of followup.
Mishriki SF; Grimsley SJ; Nabi G
J Urol; 2009 Oct; 182(4):1294-8. PubMed ID: 19683300
[TBL] [Abstract][Full Text] [Related]
3. Routine urine cytology has no role in hematuria investigations.
Mishriki SF; Aboumarzouk O; Vint R; Grimsley SJ; Lam T; Somani B
J Urol; 2013 Apr; 189(4):1255-8. PubMed ID: 23079371
[TBL] [Abstract][Full Text] [Related]
4. Does urinary cytology have a role in haematuria investigations?
Tan WS; Sarpong R; Khetrapal P; Rodney S; Mostafid H; Cresswell J; Watson D; Rane A; Hicks J; Hellawell G; Davies M; Srirangam SJ; Dawson L; Payne D; Williams N; Brew-Graves C; Feber A; Kelly JD;
BJU Int; 2019 Jan; 123(1):74-81. PubMed ID: 30003675
[TBL] [Abstract][Full Text] [Related]
5. Detection of Upper Tract Urothelial Malignancies by Computed Tomography Urography in Patients Referred for Hematuria at a Large Tertiary Referral Center.
Commander CW; Johnson DC; Raynor MC; Burke LM; Hacker KE; Hoag B; Fielding JR; Semelka RC; Lee ER
Urology; 2017 Apr; 102():31-37. PubMed ID: 28088432
[TBL] [Abstract][Full Text] [Related]
6. A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria.
Dahmcke CM; Steven KE; Larsen LK; Poulsen AL; Abdul-Al A; Dahl C; Guldberg P
Eur Urol; 2016 Dec; 70(6):916-919. PubMed ID: 27417036
[TBL] [Abstract][Full Text] [Related]
7. The significance of cystoscopy for the diagnosis of urothelial tumour.
Hattori R; Ohshima S; Ono Y; Miyake K
Int Urol Nephrol; 1993; 25(2):135-9. PubMed ID: 8365842
[TBL] [Abstract][Full Text] [Related]
8. Prospective external validation of a bladder cancer detection model.
Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
[TBL] [Abstract][Full Text] [Related]
9. [The value of urine sediment cytomorphology in the ambulatory differential diagnosis of hematuria].
Obroniecka I; Rojewska J; Wańkowicz Z
Pol Merkur Lekarski; 1998 Nov; 5(29):285-7. PubMed ID: 10101502
[TBL] [Abstract][Full Text] [Related]
10. Re: half of visible and half of recurrent visible hematuria cases have underlying pathology: prospective large cohort study with long-term followup: S. F. Mishriki, R. Vint and B. K. Somani J Urol 2012;187:1561-1565.
Thachil J
J Urol; 2013 Feb; 189(2):773-4. PubMed ID: 22986038
[No Abstract] [Full Text] [Related]
11. The clinical usefulness of nuclear matrix protein-22 in patients with end-stage renal disease and microscopic hematuria.
Trojan B; Tang A; Chandrapal J; Filleur S; Nelius T
Ren Fail; 2013; 35(1):72-6. PubMed ID: 23151051
[TBL] [Abstract][Full Text] [Related]
12. Early evaluation of hematuria in a patient receiving anticoagulant therapy and detection of malignancy.
Ripley TL; Havrda DE; Blevins S; Culkin D
Pharmacotherapy; 2004 Nov; 24(11):1638-40. PubMed ID: 15537566
[TBL] [Abstract][Full Text] [Related]
13. Can hematuria be a predictor as well as a symptom or sign of bladder cancer?
Friedman GD; Carroll PR; Cattolica EV; Hiatt RA
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):993-6. PubMed ID: 8959322
[TBL] [Abstract][Full Text] [Related]
14. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
15. Assessment of asymptomatic microscopic hematuria in adults.
Sharp VJ; Barnes KT; Erickson BA
Am Fam Physician; 2013 Dec; 88(11):747-54. PubMed ID: 24364522
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
Goel MC; Mahendra V; Roberts JG
J Urol; 2003 Mar; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
[TBL] [Abstract][Full Text] [Related]
17. 'One stop' haematuria clinic in Fremantle Hospital, Western Australia: a report of the first 500 patients.
Ooi WL; Lee F; Wallace DM; Hayne D
BJU Int; 2011 Nov; 108 Suppl 2():62-6. PubMed ID: 22085132
[TBL] [Abstract][Full Text] [Related]
18. Kidney, Ureteral, and Bladder Cancer: A Primer for the Internist.
Arora HC; Fascelli M; Zhang JH; Isharwal S; Campbell SC
Med Clin North Am; 2018 Mar; 102(2):231-249. PubMed ID: 29406055
[TBL] [Abstract][Full Text] [Related]
19. A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria.
O'Sullivan P; Sharples K; Dalphin M; Davidson P; Gilling P; Cambridge L; Harvey J; Toro T; Giles N; Luxmanan C; Alves CF; Yoon HS; Hinder V; Masters J; Kennedy-Smith A; Beaven T; Guilford PJ
J Urol; 2012 Sep; 188(3):741-7. PubMed ID: 22818138
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis.
Patel A; Soonawalla P; Shepherd SF; Dearnaley DP; Kellett MJ; Woodhouse CR
J Urol; 1996 Mar; 155(3):868-74. PubMed ID: 8583595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
